# Hypofractionated Stereotactic Radiation Therapy of Brain Metastases: Evaluation of Whole-brain Radiotherapy

> **NCT02913534** · — · COMPLETED · sponsor: **Institut de Cancérologie de Lorraine** · enrollment: 100 (actual)

## Conditions studied

- Brain Metastasis

## Interventions

- **RADIATION:** whole brain radiotherapy

## Key facts

- **NCT ID:** NCT02913534
- **Lead sponsor:** Institut de Cancérologie de Lorraine
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2014-03
- **Primary completion:** 2014-06
- **Final completion:** 2014-06
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2016-09-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02913534

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02913534, "Hypofractionated Stereotactic Radiation Therapy of Brain Metastases: Evaluation of Whole-brain Radiotherapy". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT02913534. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*